Product overview For years, artificial intelligence (AI) has attracted the attention of society and sparked enthusiasm for its potential to improve our lives. AI is already part of our daily lives, as well as our interactions with media, transport and communication.
New York, May 13, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of its “Artificial Intelligence in the Cancer Market” report – https://www.reportlinker.com/p06276452/?utm_source=GNW
AI applications in healthcare are gaining popularity as a way to improve disease diagnosis, management and the creation of successful treatments. Given the huge number of patients diagnosed with cancer and the large amount of data collected during treatment, AI applications to improve oncology care are of particular importance. During medical operations, artificial intelligence helps doctors retrieve information, interpret images and plan therapy. It also makes the work of health professionals easier.
The global artificial intelligence market in cancer is projected to project a remarkable CAGR of XX.X% by 2030
Global Artificial Intelligence in Cancer will surpass USD XXXX Billion in 2030 from USD XXXX Billion in 2020 at a CAGR of XX.X% in the coming years i.e. 2021-30. Some of the key variables driving revenue growth in the market include an increase in the influx of digital patient data, a growing need to minimize healthcare costs, and an increasing need for personalized medication. Another important reason that has increased the need to study and identify diseases at an early stage is the increase in the prevalence of chronic diseases such as cancer. Deep learning technology would make it easy to anticipate diseases based on past health data. In addition, content analytics, Natural Language Processing (NLP) technologies and artificial intelligence (AI) can help with rapid patient diagnosis.
Recent Highlights in the Global Artificial Intelligence in Cancer Market:
In August 2020, Digital Diagnostics Inc., formerly known as IDx, acquired 3Derm Systems Inc. The acquisition was intended to expand 3DermTriage’s dermatologic telemedicine capabilities and prepare its autonomous AI skin cancer diagnosis device, 3DermSpot, for FDA approval.
In September 2019, to create applications for its Edison AI platform, GE Healthcare signed a collaboration agreement with five local Chinese software development companies-12Sigma Technologies, Shukun Technology, Biomind, YITU Technology and Yizhun Medical AI. These key partners are expected to deliver mature software products that will enable GE Healthcare’s digital transition to run smoothly.
Global Artificial Intelligence in Cancer Market: Segments
Targeted Therapy Segment Grows at Highest CAGR During 2020-30
Global Artificial Intelligence in Cancer Market is segmented by product type into Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Phototherapy, Targeted Therapy, Gene Therapy, Sonodynamic Therapy. Among this targeted therapy is expected to have the highest growth in the forecast period. This can be attributed to the discovery of the molecular targets of cancer cells. Recent advances in cellular technology and gene therapy have improved our understanding of tumor cells and their metabolism at the molecular level, leading to the development of tailor-made cancer drug treatments.
Lung Cancer Segment Grows at Highest CAGR in 2020-30
The global cancer artificial intelligence market is segmented by cancer type into lung, breast, melanoma, colorectal, prostate, and others. The high prevalence of breast cancer around the world is a major contributor to the significant share of this segment. However, the lung cancer category is expected to grow the most over the projection period. The rising prevalence of lung cancer around the world, as well as the growing demand for early detection, are driving the rise of this segment.
To help end users overcome the shortage of radiologists, deliver value-based care, early detection and diagnosis of disease, and maintain a competitive advantage in the marketplace, companies are increasingly focusing on expanding their geographic reach and introducing newer ones. , innovative solutions through various strategies , including partnerships, product launches and collaborations.
The reluctance of medical professionals to use AI-based technology
With the rapid rise of digital health, healthcare providers can now help patients with innovative treatment techniques. AI technologies provide doctors with tools to diagnose and treat patients more efficiently. Physicians, on the other hand, have shown a reluctance to adopt new technology. For example, there is a widespread belief among medical professionals that AI will eventually replace doctors. Physicians and radiologists believe that qualities such as empathy and persuasion are human abilities, and that advances in technology cannot completely eliminate the need for a physician. In addition, there is a fear that patients will become too dependent on these technologies and forego important personal treatments, jeopardizing long-term doctor-patient relationships.
Global Artificial Intelligence in Cancer Market: Major Players:
Company overview, business strategy, key product offerings, financial performance, key performance indicators, risk analysis, recent development, regional presence, SWOT analysis
Day zero diagnostics
Butterfly Network, Inc.
Zebra Medical Vision
Global Artificial Intelligence in Cancer Market: Regions:
The global Artificial Intelligence in Cancer market has been segmented into five major regions based on regional analysis. These include North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa. Global AI in Cancer in North America had the largest market share in the year 2020. However, the APAC market is expected to grow the fastest over the forecast period due to emerging market growth strategies, improved medical diagnostic infrastructure, an aging population, rising cancer prevalence, favorable government initiatives for AI in healthcare and an increase in the number of COVID-19 positive patients.
Global Artificial Intelligence in Cancer Market is further segmented by Regions into:
North America Market Size, Share, Trends, Opportunity, Year-over-Year Growth, CAGR – United States and Canada
Market Size, Share, Trends, Opportunities, Year-over-Year Growth in Latin America, CAGR – Mexico, Argentina, Brazil & Rest of Latin America
Market Size, Share, Trends, Opportunities, Year-over-Year Growth in Europe, CAGR – United Kingdom, France, Germany & Rest of Europe
Asia-Pacific Market Size, Share, Trends, Opportunity, Year-over-Year Growth, CAGR – China, Japan, Australia & Rest of APAC
Market Size, Share, Trends, Opportunity, Year-over-Year Growth in Middle East and Africa, CAGR – North Africa, Israel, GCC, South Africa & Rest of MENA
Global Artificial Intelligence in Cancer Market Report Also Includes:
Artificial intelligence in cancer segments:
By type of cancer
By end user
Artificial intelligence in cancer Market dynamics
Artificial Intelligence in Cancer Market Size
Supply & demand
Current Market Trends/Problems/Challenges
Competition and companies involved in the market
Market value chain
Market factors and constraints
Read the full report: https://www.reportlinker.com/p06276452/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data, so you get all the market research you need instantly and in one place.
CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001